Split History
ETFs Holding VVUS »    VVUS Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VIVUS is a pharmaceutical company with approved therapies and one product candidate in clinical development. Qsymia® (phentermine and topiramate extended release) is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. PANCREAZE®/ PANCREASE® MT (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. STENDRA® (avanafil) is approved by FDA for erectile dysfunction (ED) and by the European Commission under the trade name SPEDRA, for the treatment of ED in the European Union.VI-0106 (tacrolimus) is in clinical development and is being studied in patients with pulmonary arterial hypertension. According to our VVUS split history records, VVUS has had 2 splits.
VVUS split history picture
VVUS (VVUS) has 2 splits in our VVUS split history database. The first split for VVUS took place on June 24, 1997. This was a 2 for 1 split, meaning for each share of VVUS owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. VVUS's second split took place on September 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of VVUS owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 200 share position following the split.

When a company such as VVUS splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as VVUS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the VVUS split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VVUS shares, starting with a $10,000 purchase of VVUS, presented on a split-history-adjusted basis factoring in the complete VVUS split history. VVUS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/14/2011
End date: 07/16/2020
Start price/share: $68.10
End price/share: $0.47
Dividends collected/share: $0.00
Total return: -99.31%
Average Annual Total Return: -41.56%
Starting investment: $10,000.00
Ending investment: $69.03
Years: 9.26
Date Ratio
06/24/19972 for 1
09/11/20181 for 10
VVUS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

WAT Split History
WGBS Split History
WOOF Split History
XBIO Split History
XOMA Split History
XRAY Split History
XTNT Split History
ZGNX Split History
ZLCS Split History
ZSAN Split History

Also explore: VVUS shares outstanding history

Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

VVUS Insider Buying

VVUS Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.